Newsbenzinga
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
· Published
Article summary
Sunshine Biopharma advances its lead coronavirus drug candidate into IND-enabling studies after strong preclinical results in animal models.
An excerpt from the original article.
Comments —
Loading comments…